Culture-Based and Culture-Independent Bacteriologic Analysis of Cystic Fibrosis Respiratory Specimens

Journal of Clinical Microbiology

Volumn 54, Issue 3, 2016, Pages 613-619

  Mahboubi, Mona A ^a   Carmody, Lisa A ^a   Foster, Bridget K ^a   Kalikin, Linda M ^a   VanDevanter, Donald R ^b   LiPuma, John J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACHROMOBACTER; ARTICLE; BACTERIAL LOAD; BACTERIUM CULTURE; BACTERIUM DETECTION; BURKHOLDERIA; CYSTIC FIBROSIS; DNA SEQUENCE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SPUTUM ANALYSIS; STAPHYLOCOCCUS; STENOTROPHOMONAS; STREPTOCOCCUS; ADOLESCENT; ADULT; BACTERIAL INFECTION; BACTERIUM; CHILD; CLASSIFICATION; COMPARATIVE STUDY; COMPLICATION; EVALUATION STUDY; FEMALE; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; MOLECULAR DIAGNOSIS; PRESCHOOL CHILD; PROCEDURES; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

ADOLESCENT; ADULT; BACTERIA; BACTERIAL INFECTIONS; BACTERIOLOGICAL TECHNIQUES; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84959541626     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02299-15     Document Type: Article

References (31)

1. Gilligan PH. 1991. Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev 4:35-51.
2. LiPuma JJ. 2010. The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev 23:299-323. http://dx.doi.org/10.1128/CMR.00068-09.
3. Huang YJ, LiPuma JJ. 23 December 2015. The microbiome in cystic fibrosis. Clin Chest Med http://dx.doi.org/10.1016/j.ccm.2015.10.003.
4. Hansen SK, Rau MH, Johansen HK, Ciofu O, Jelsbak L, Yang L, Folkesson A, Jarmer HO, Aanaes K, von Buchwald C, Hoiby N, Molin S. 2012. Evolution and diversification of Pseudomonas aeruginosa in the paranasal sinuses of cystic fibrosis children have implications for chronic lung infection. ISME J 6:31-45. http://dx.doi.org/10.1038/ismej.2011.83.
5. Venkataraman A, Bassis CM, Beck JM, Young VB, Curtis JL, Huffnagle GB, Schmidt TM. 2015. Application of a neutral community model to assess structuring of the human lung microbiome. mBio 6:e02284-14.
6. Bassis CM, Erb-Downward JR, Dickson RP, Freeman CM, Schmidt TM, Young VB, Beck JM, Curtis JL, Huffnagle GB. 2015. Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals. mBio 6:e00037.
7. Cox MJ, Allgaier M, Taylor B, Baek MS, Huang YJ, Daly RA, Karaoz U, Andersen GL, Brown R, Fujimura KE, Wu B, Tran D, Koff J, Kleinhenz ME, Nielson D, Brodie EL, Lynch SV. 2010. Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients. PLoS One 5(6):e11044. http://dx.doi.org/10.1371/journal.pone.0011044.
8. Zhao J, Schloss PD, Kalikin LM, Carmody LA, Foster BK, Petrosino JF, Cavalcoli JD, VanDevanter DR, Murray S, Li JZ, Young VB, LiPuma JJ. 2012. Decade-long bacterial community dynamics in cystic fibrosis airways. Proc Natl Acad Sci U S A 109:5809-5814. http://dx.doi.org/10.1073/pnas.1120577109.
9. Stokell JR, Gharaibeh RZ, Hamp TJ, Zapata MJ, Fodor AA, Steck TR. 2015. Analysis of changes in diversity and abundance of the microbial community in a cystic fibrosis patient over a multiyear period. J Clin Microbiol 53:237-247. http://dx.doi.org/10.1128/JCM.02555-14.
10. Stressmann FA, Rogers GB, Van Der Gast CJ, Marsh P, Vermeer LS, Carroll MP, Hoffman L, Daniels TW, Patel N, Forbes B, Bruce KD. 2012. Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience. Thorax 67:867-873. http://dx.doi.org/10.1136/thoraxjnl-2011-200932.
11. Klepac-Ceraj V, Lemon KP, Martin TR, Allgaier M, Kembel SW, Knapp AA, Lory S, Brodie EL, Lynch SV, Bohannan BJ, Green JL, Maurer BA, Kolter R. 2010. Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa. Environ Microbiol 12:1293-1303. http://dx.doi.org/10.1111/j.1462-2920.2010.02173.x.
12. Carmody LA, Zhao J, Schloss PD, Petrosino JF, Murray S, Young VB, Li JZ, LiPuma JJ. 2013. Changes in cystic fibrosis airway microbiota at pulmonary exacerbation. Ann Am Thorac Soc 10:179-187. http://dx.doi.org/10.1513/AnnalsATS.201211-107OC.
13. LiPuma JJ. 2015. Assessing airway microbiota in cystic fibrosis: What more should be done? J Clin Microbiol 53:2006-2007. http://dx.doi.org/10.1128/JCM.01218-15.
14. Gilligan PH, Kiska DL, Appleman MD. 2006. Cumitech 43: Cystic fibrosis microbiology. ASM Press, Washington, DC.
15. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, Lesniewski RA, Oakley BB, Parks DH, Robinson CJ, Sahl JW, Stres B, Thallinger GG, Van Horn DJ, Weber CF. 2009. Introducing mothur: Open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 75:7537-7541. http://dx.doi.org/10.1128/AEM.01541-09.
16. Cole JR, Wang Q, Cardenas E, Fish J, Chai B, Farris RJ, Kulam-Syed-Mohideen AS, McGarrell DM, Marsh T, Garrity GM, Tiedje JM. 2009. The Ribosomal Database Project: Improved alignments and new tools for rRNA analysis. Nucleic Acids Res 37:D141-D145. http://dx.doi.org/10.1093/nar/gkn879.
17. Sibley CD, Grinwis ME, Field TR, Eshaghurshan CS, Faria MM, Dowd SE, Parkins MD, Rabin HR, Surette MG. 2011. Culture enriched molecular profiling of the cystic fibrosis airway microbiome. PLoS One 6(7): E22702. http://dx.doi.org/10.1371/journal.pone.0022702.
18. Zhao J, Carmody LA, Kalikin LM, Li J, Petrosino JF, Schloss PD, Young VB, LiPuma JJ. 2012. Impact of enhanced Staphylococcus DNA extraction on microbial community measures in cystic fibrosis sputum. PLoS One 7(3):e33127. http://dx.doi.org/10.1371/journal.pone.0033127.
19. Parkins MD, Sibley CD, Surette MG, Rabin HR. 2008. The Streptococcus milleri group-an unrecognized cause of disease in cystic fibrosis: A case series and literature review. Pediatr Pulmonol 43:490-497. http://dx.doi.org/10.1002/ppul.20809.
20. Sibley CD, Parkins MD, Rabin HR, Duan K, Norgaard JC, Surette MG. 2008. A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients. Proc Natl Acad Sci U S A 105:15070-15075. http://dx.doi.org/10.1073/pnas.0804326105.
21. Whiteson KL, Bailey B, Bergkessel M, Conrad D, Delhaes L, Felts B, Harris JK, Hunter R, Lim YW, Maughan H, Quinn R, Salamon P, Sullivan J, Wagner BD, Rainey PB. 2014. The upper respiratory tract as a microbial source for pulmonary infections in cystic fibrosis. Parallels from island biogeography. Am J Respir Crit Care Med 189:1309-1315. http://dx.doi.org/10.1164/rccm.201312-2129PP.
22. Harris JK, De Groote MA, Sagel SD, Zemanick ET, Kapsner R, Penvari C, Kaess H, Deterding RR, Accurso FJ, Pace NR. 2007. Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proc Natl Acad Sci U S A 104:20529-20533. http://dx.doi.org/10.1073/pnas.0709804104.
23. Tunney MM, Field TR, Moriarty TF, Patrick S, Doering G, Muhlebach MS, Wolfgang MC, Boucher R, Gilpin DF, McDowell A, Elborn JS. 2008. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am J Respir Crit Care Med 177:995-1001. http://dx.doi.org/10.1164/rccm.200708-1151OC.
24. Worlitzsch D, Rintelen C, Bohm K, Wollschlager B, Merkel N, Borneff-Lipp M, Doring G. 2009. Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients. Clin Microbiol Infect 15:454-460. http://dx.doi.org/10.1111/j.1469-0691.2008.02659.x.
25. Zemanick ET, Wagner BD, Sagel SD, Stevens MJ, Accurso FJ, Harris JK. 2010. Reliability of quantitative real-time PCR for bacterial detection in cystic fibrosis airway specimens. PLoS One 5(11):e15101. http://dx.doi.org/10.1371/journal.pone.0015101.
26. Fodor AA, Klem ER, Gilpin DF, Elborn JS, Boucher RC, Tunney MM, Wolfgang MC. 2012. The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations. PLoS One 7(9):e45001. http://dx.doi.org/10.1371/journal .pone.0045001.
27. Brown PS, Pope CE, Marsh RL, Qin X, McNamara S, Gibson R, Burns JL, Deutsch G, Hoffman LR. 2014. Directly sampling the lung of a young child with cystic fibrosis reveals diverse microbiota. Ann Am Thorac Soc 11:1049-1055. http://dx.doi.org/10.1513/AnnalsATS.201311-383OC.
28. Quinn RA, Lim YW, Maughan H, Conrad D, Rohwer F, Whiteson KL. 2014. Biogeochemical forces shape the composition and physiology of polymicrobial communities in the cystic fibrosis lung. mBio 5:e00956-13.
29. Cowley ES, Kopf SH, LaRiviere A, Ziebis W, Newman DK. 2015. Pediatric cystic fibrosis sputum can be chemically dynamic, anoxic, and extremely reduced due to hydrogen sulfide formation. mBio 6:e00767.
30. Flight WG, Smith A, Paisey C, Marchesi JR, Bull MJ, Norville PJ, Mutton KJ, Webb AK, Bright-Thomas RJ, Jones AM, Mahenthiralingam E. 2015. Rapid detection of emerging pathogens and loss of microbial diversity associated with severe lung disease in cystic fibrosis. J Clin Microbiol 53:2022-2029. http://dx.doi.org/10.1128/JCM.00432-15.
31. Micallef L, Rodgers P. 2014. eulerAPE: Drawing area-proportional 3-Venn diagrams using ellipses. PLoS One 9(7):e101717. http://dx.doi.org/10.1371/journal.pone.0101717.